Home » Topics » Briefs » Other news to note

Other news to note
RSS

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

SB-221420 in development for stroke

May 17, 1996

SB-238592: Antiinflammatory neuroprotectant in clinical phase

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Receptagen demerger on the table at AGM

May 17, 1996

Hafslund Nycomed demerger approved at AGM

May 17, 1996

Allergan calls off merger discussions with Pharmacia & Upjohn

May 17, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Progene Partners dissolved upon completion of goals

May 10, 1996

OncoRx gets new identity: Vion Pharmaceuticals

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...